Pfizer MDL's $91M Atty Fees Misallocated, Firm Says
Bernstein Liebhard LLP told a Massachusetts federal judge Thursday that the plaintiffs' steering committee in multidistrict litigation accusing Pfizer Inc. of illegally marketing Neurontin for off-label use was unfairly doling out...To view the full article, register now.
Already a subscriber? Click here to view full article